It was reported application site hypersensitivity to chloraprep.Initial information was processed with additional information received on 05-jan-2021.This solicited report received from health care professional and patient via ppsphn002323: sp services accredo, concerned a [omitted], and height was not reported.The patient's concurrent conditions included primary pulmonary hypertension.The patient was treated with macitentan (tablet, oral, batch number: zm021b0101 expiry: 30-nov-2023) 10 mg, 1 time every 1 day, therapy dates were not reported for primary pulmonary hypertension non-company suspect drugs.Included: chlorhexidine gluconate/isopropanol (form of admin, route of admin, and batch number were not reported) dose, frequency, and therapy dates were not reported; and treprostmil sodium (form of admin unknown, subcutaneous, batch number was not reported) dose, frequency, and therapy dates were not reported, and dose, frequency, and therapy dates were not reported for an unspecified indication.No concomitant medications were reported on an unspecified date, the patient changed from remodulm subcutaneous to remodulin intravenous (iv) therapy the patient reported she was doing just as good at current of remodulin iv as she did with the subcutaneous dose.On an unspecified date, the patient had severe subcutaneous site pam which impacted her quality of life.The patient reported she also had occasional headache and nausea with remodulin iv but there was no leg pain like she did with the subcutaneous dose the patient reported sensitivity to chloroprep and requested iodine dressing change kits on an unspecified date, the surgeon placed patient's hickman m the wrong place so the patient will go back to the hospital on 08-jan-2021 to have it replaced.The action taken with macitentan, treprostinil sodium, and chlorhexidine gluconate/isopropanol was not reported.The outcome of the severe subcut site pam, occasional headache, nausea with iv, sensitivity to chloraprep, surgeon placed hickman in the wrong place and leg pain was not reported.The reporter provided no causality assessment.Company causality between macitentan, and surgeon placed hickman in the wrong place, severe subcut site pain, nausea with iv, sensitivity to chloraprep, and leg pam was not related, and between macitentan, and occasional headache was related.This report was non-senous.This case, involving the same patient is linked to (b)(4).
|